Wesley covers the micro- and nano-cap tape for The MicroCap Herald, reporting on outsized moves with careful attention to float, volume, and reversal risk.
Articles by Wesley Stroud
bioAffinity clears two Nasdaq deficiencies and its hearing is cancelled, leaving about 592,373 shares outstanding
A Nasdaq letter dated Sept. 8 confirmed compliance with both the minimum bid price rule and the rights-and-warrants rule, cancelling a Hearings Panel appearance the company had been pushed into because a reverse split within the prior year disqualified it from any cure period. Two splits in eleven months compound to 450-to-1, above the 250-to-1, two-year threshold written into the same rule.
BioRestorative's 1-for-20 Split Opens Today With About 1.4 Million Shares Outstanding
The consolidation also takes authorized common stock from 1.5 billion shares back to 75 million — the level shareholders voted to leave five months ago. The company's Nasdaq bid-price deadline is Sept. 22.
Two Nasdaq Companies Got Second Bid-Price Windows Running to March 1, 2027. A Third Closed Its Case Today
Alpha Compute and DeFi Technologies each disclosed an additional 180-day period this week, both ending on the same date despite deficiency notices issued three days apart in March. CLPS said on Sept. 4 that it cleared the $1.00 threshold for ten sessions running to Sept. 2.
Edible Garden Regains Nasdaq $1.00 Bid-Price Compliance; the Hearings Panel Keeps Jurisdiction Through Nov. 23
The controlled-environment agriculture company said on Sept. 2 that Nasdaq had confirmed it has regained compliance with the $1.00 minimum closing bid price rule. The company said in July that its closing bid price had stayed at or above $1.00 since a 1-for-45 reverse split took effect on July 13, and the Panel that granted continued listing retains jurisdiction through Nov. 23.

Short interest keeps building on Nasdaq's smallest tier while the big-cap tier unwinds
Nasdaq's July 31 settlement figures, published Wednesday, show Capital Market short interest up almost 10% since mid-June even as the Global Market tier shrank. Days to cover on the small tier has climbed for two straight reports, which says more about disappearing volume than about conviction.
Socket Mobile Rockets 450% on Distribution Pact as Micro-Cap Momentum Trades Return
A distribution partnership sent the $17 million scanner maker up more than 450% in a single session, leading a cluster of outsized micro-cap moves that traders say demands caution as much as attention.
Sionna's 92% Wipeout Shows How Fast a Clinical-Stage Biotech Can Land in Micro-Cap Territory
A failed cystic fibrosis readout erased more than nine-tenths of Sionna Therapeutics' value in a single session, leaving the company trading below its own cash pile and drawing a shareholder-firm investigation by Tuesday morning.